• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新千年的药物经济学。制药行业视角。

Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.

作者信息

Thwaites R, Townsend R J

机构信息

Glaxo Wellcome, Greenford, Middlesex, England.

出版信息

Pharmacoeconomics. 1998 Feb;13(2):175-80. doi: 10.2165/00019053-199813020-00002.

DOI:10.2165/00019053-199813020-00002
PMID:10178645
Abstract

The primary purpose of pharmacoeconomic research is to assist in making healthcare decisions. Rapid growth in the supply of pharmacoeconomic data over the past few years suggests that pharmacoeconomics can be of help in delivering good, cost-effective healthcare. Greater challenges in decision-making coupled with improvements in the techniques of pharmacoeconomic research point to a greater role for pharmacoeconomics into the new millennium. This in turn will have consequences for companies in the pharmaceutical industry. More successful access to markets and better commercialisation of products will be the rewards for those companies committing to pharmacoeconomics and to the broader goal of delivering value for money in healthcare.

摘要

药物经济学研究的主要目的是协助做出医疗保健决策。过去几年中药物经济学数据供应的快速增长表明,药物经济学有助于提供优质、具有成本效益的医疗保健服务。决策方面面临的更大挑战以及药物经济学研究技术的改进表明,在新千年里药物经济学将发挥更大作用。这反过来将对制药行业的公司产生影响。对于那些致力于药物经济学以及实现医疗保健性价比这一更广泛目标的公司来说,更成功地进入市场和更好地实现产品商业化将是回报。

相似文献

1
Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.新千年的药物经济学。制药行业视角。
Pharmacoeconomics. 1998 Feb;13(2):175-80. doi: 10.2165/00019053-199813020-00002.
2
[Pharmacoeconomics - Challenges for Health Professionals].[药物经济学——卫生专业人员面临的挑战]
Acta Med Croatica. 2016 Apr;70(2):117-23.
3
Emerging role of pharmacoeconomics in the research and development decision-making process.药物经济学在研发决策过程中的新作用。
Pharmacoeconomics. 2001;19(7):753-66. doi: 10.2165/00019053-200119070-00004.
4
Penny and pound wise: pharmacoeconomics from a governmental perspective.小事精明,大事糊涂:政府视角下的药物经济学
Pharmacoeconomics. 2005;23(3):219-26. doi: 10.2165/00019053-200523030-00003.
5
The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report.药学院在满足制药行业药物经济学需求方面的作用:会议报告
Clin Ther. 1994 May-Jun;16(3):523-37; discussion 522.
6
Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?药物研发中的科学、药物经济学与伦理学:可持续的未来前景?
Nat Rev Drug Discov. 2004 Jun;3(6):521-6. doi: 10.1038/nrd1418.
7
What is next for pharmacoeconomics and outcomes research in Asia?亚洲药物经济学与结果研究的未来走向如何?
Value Health. 2004 Mar-Apr;7(2):118-32. doi: 10.1111/j.1524-4733.2004.72330.x.
8
Pharmacoeconomics and formulary decision making.药物经济学与处方集决策
Pharmacoeconomics. 1996;9 Suppl 1:16-25. doi: 10.2165/00019053-199600091-00005.
9
[Pharmacoeconomic impact of compliance].[依从性的药物经济学影响]
Acta Pharm Hung. 2010;80(2):75-80.
10
Pharmacoeconomics and immunotherapy.药物经济学与免疫疗法
Eur Ann Allergy Clin Immunol. 2007;39 Spec No:12-6.

引用本文的文献

1
Pharmacoeconomic Assessment of Antiallergic Drugs by Comparing Serum Immunoglobulin E Level as a Diagnostic and Monitoring Indicator of Allergic Rhinitis in Rural Population of India.通过比较血清免疫球蛋白E水平作为印度农村人口过敏性鼻炎诊断和监测指标对抗过敏药物进行药物经济学评估。
Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):928-933. doi: 10.1007/s12070-023-03488-9. Epub 2023 Jan 29.
2
Pharmacoeconomics in Africa: needs, prospect and challenges.非洲的药物经济学:需求、前景与挑战。
J Pharm Policy Pract. 2021 May 31;14(1):47. doi: 10.1186/s40545-021-00328-5.
3
Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.

本文引用的文献

1
The Danish approach to standards for economic evaluation methodologies.丹麦对经济评估方法标准的处理方式。
Pharmacoeconomics. 1997 Dec;12(6):627-36. doi: 10.2165/00019053-199712060-00003.
2
Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain.药物治疗的经济学评估:英国初级保健处方顾问的态度
Health Policy. 1997 Jul;41(1):61-72. doi: 10.1016/s0168-8510(97)00013-4.
3
Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America.
药学福利管理:增强药物经济学在优化决策中的适用性。
Pharmacoeconomics. 2002;20(1):9-21. doi: 10.2165/00019053-200220010-00002.
4
Using health outcomes data to inform decision-making: a pharmaceutical industry perspective.利用健康结果数据为决策提供信息:制药行业视角
Pharmacoeconomics. 2001;19 Suppl 2:27-31. doi: 10.2165/00019053-200119002-00005.
5
Emerging role of pharmacoeconomics in the research and development decision-making process.药物经济学在研发决策过程中的新作用。
Pharmacoeconomics. 2001;19(7):753-66. doi: 10.2165/00019053-200119070-00004.
6
Pharmacoeconomics and health policy. Current applications and prospects for the future.药物经济学与卫生政策。当前应用及未来展望。
Pharmacoeconomics. 1999 Nov;16(5 Pt 1):425-32. doi: 10.2165/00019053-199916050-00001.
药物经济学研究的方法学与实施原则。美国制药研究与制造商协会。
Pharmacoeconomics. 1995 Aug;8(2):169-74. doi: 10.2165/00019053-199508020-00008.
4
A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.意大利药物经济学指南提案 马里奥·内格里研究所卫生经济中心
Pharmacoeconomics. 1995 Jan;7(1):1-6. doi: 10.2165/00019053-199507010-00001.
5
Quality of life and clinical trials.生活质量与临床试验。
Lancet. 1995 Jul 1;346(8966):1-2.